Kate Rochlin
Chief Operating Officer bei IN8BIO, INC.
Vermögen: 20 718 $ am 31.03.2024
Profil
Kate Rochlin is the founder of Immunovent LLC.
She is currently the Executive Director at Solution Lab, Inc. since 2019 and the Chief Operating Officer at IN8bio, Inc. since 2020.
Previously, she worked as the Director-Scientific Affairs at Filament BioSolutions, Inc. and as the Chief Business Officer at Curadigm SAS in 2020.
Dr. Rochlin completed her undergraduate degree at the University of Pennsylvania and obtained her doctorate from Weill Cornell Medical College.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
IN8BIO, INC.
0,04% | 07.02.2024 | 17 558 ( 0,04% ) | 20 718 $ | 31.03.2024 |
Aktive Positionen von Kate Rochlin
| Unternehmen | Position | Beginn |
|---|---|---|
| IN8BIO, INC. | Chief Operating Officer | 01.12.2020 |
| Solution Lab, Inc. | Director/Board Member | 01.10.2019 |
Ehemalige bekannte Positionen von Kate Rochlin
| Unternehmen | Position | Ende |
|---|---|---|
| Curadigm SAS | Corporate Officer/Principal | 01.08.2020 |
Immunovent LLC
 Immunovent LLC Medical/Nursing ServicesHealth Services Immunovent LLC is a biotech company based in New York, NY. Immunovent is revolutionizing allergy diagnostics by coupling existing clinical practices with their patented lamb-dx test. The lamb-dx test detects small amounts of antigen-specific ige from symptomatic areas of the body, such as the mouth and the nose, through a gentle and easy mucosal brush sampling procedure and a proprietary diagnostic assay. This allows for the rapid and safe diagnosis of common allergies without the inconveniences and issues of conventional skin prick and blood testing. The private company was founded by Kate Rochlin and Thomas P. Cirrito. Thomas P. Cirrito has been the CEO since incorporation. | Founder | - |
Filament BioSolutions, Inc.
 Filament BioSolutions, Inc. Pharmaceuticals: OtherHealth Technology Filament BioSolutions, Inc. develops medical and functional foods for diseases. The company is based in Long Island City, NY. The company was founded by Thomas P. Cirrito. Thomas P. Cirrito has been the CEO since incorporation. | Chief Tech/Sci/R&D Officer | - |
Ausbildung von Kate Rochlin
| University of Pennsylvania | Undergraduate Degree |
| Weill Cornell Medical College | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| IN8BIO, INC. | Health Technology |
| Private Unternehmen | 4 |
|---|---|
Filament BioSolutions, Inc.
Filament BioSolutions, Inc. Pharmaceuticals: OtherHealth Technology Filament BioSolutions, Inc. develops medical and functional foods for diseases. The company is based in Long Island City, NY. The company was founded by Thomas P. Cirrito. Thomas P. Cirrito has been the CEO since incorporation. | Health Technology |
Immunovent LLC
Immunovent LLC Medical/Nursing ServicesHealth Services Immunovent LLC is a biotech company based in New York, NY. Immunovent is revolutionizing allergy diagnostics by coupling existing clinical practices with their patented lamb-dx test. The lamb-dx test detects small amounts of antigen-specific ige from symptomatic areas of the body, such as the mouth and the nose, through a gentle and easy mucosal brush sampling procedure and a proprietary diagnostic assay. This allows for the rapid and safe diagnosis of common allergies without the inconveniences and issues of conventional skin prick and blood testing. The private company was founded by Kate Rochlin and Thomas P. Cirrito. Thomas P. Cirrito has been the CEO since incorporation. | Health Services |
| Curadigm SAS | |
| Solution Lab, Inc. |
